The Osteopore Ltd (ASX: OSX) share price is surging today after the company announced it has signed a new research deal.
The medical technology company’s share price soared 33% higher to 28 cents in early trading, before retreating slightly to 26 cents apiece at the time of writing. That’s still 23.81% higher than the previous closing price.
Osteopore engineers and commercialises products that regenerate the tissues in the bones.
What did the company announce today?
In today’s release, Osteopore advised it has signed an agreement for an $18.7 million project with two major research institutes in Singapore.
The company will work with the National Dental Research Institute and the Agency for Science, Technology and Research to develop jaw implants.
As part of the study, the company said it would test some of its patented products for potential use in dental applications.
Osteopore would use the research results to help develop jaw implants that would ultimately simplify future dental procedures.
If this research proved successful, the company said it could tap into a global market worth an estimated $1.26 billion.
Osteopore will commit $1.8 million towards the project over three years.
Management comment
Welcoming the announcement, Osteopore CEO Goh Seng said:
We are very thankful to participate and lead this grant and for the support of all the institutions involved in this research.
We strongly believe in developing and commercialising regenerative technologies for the well-being of patients.
Company chair Mark Leong added:
We are constantly developing new and better applications for our technology as well as growing addressable markets. This partnership project is a significant step for Osteopore.
Osteopore share price snap shot
Osteopore investors have experienced a turbulent year in 2021, falling 50% since January. In the past 12 months, the Osteopore share price has also dropped by around 50%.
Osteopore reached a yearly high of 53 cents in April, before dropping to a yearly low of 20 cents last week.
The company’s total market capitalisation is around $30 million, based on the current share price.
The post Osteopore (ASX:OSX) share price rockets 24% on major new deal appeared first on The Motley Fool Australia.
Should you invest $1,000 in Osteopore right now?
Before you consider Osteopore, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Osteopore wasn’t one of them.
The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
*Returns as of August 16th 2021
More reading
- Leading brokers name 3 ASX shares to buy today
- Here’s why the Neometals (ASX:NMT) share price is surging 6% today
- Johns Lyng (ASX:JLG) shares surge 19% out of trading halt. Here’s why
- Why are ASX ETFs getting so much attention today?
- What is the better buy: Bitcoin vs. Ethereum
The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
from The Motley Fool Australia https://ift.tt/3lYBVut
Leave a Reply